BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grottenthaler JM, Werner CR, Steurer M, Spengler U, Berg T, Engelmann C, Wedemeyer H, von Hahn T, Stremmel W, Pathil A, Seybold U, Schott E, Blessin U, Sarrazin C, Welker MW, Harrer E, Scholten S, Hinterleitner C, Lauer UM, Malek NP, Berg CP. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. PLoS One 2018;13:e0197544. [PMID: 29874250 DOI: 10.1371/journal.pone.0197544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Dalla E, Bulfoni M, Cesselli D, Pravisani R, Hidaka M, Eguchi S, Baccarani U. Reinfection of Transplanted Livers in HCV- and HCV/HIV-Infected Patients Is Characterized by a Different MicroRNA Expression Profile. Cells 2022;11:690. [DOI: 10.3390/cells11040690] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bulfoni M, Pravisani R, Dalla E, Cesselli D, Hidaka M, Di Loreto C, Eguchi S, Baccarani U. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation. J Med Virol 2021;93:4992-5000. [PMID: 33818800 DOI: 10.1002/jmv.26999] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Papp KA, Beecker J, Cooper C, Kirchhof MG, Pozniak AL, Rockstroh JK, Dutz JP, Gooderham MJ, Gniadecki R, Hong CH, Lynde CW, Maari C, Poulin Y, Vender RB, Walmsley SL. Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel. Dermatol Ther (Heidelb) 2022. [PMID: 35445963 DOI: 10.1007/s13555-022-00722-0] [Reference Citation Analysis]
4 Diaz NA, Ambrosioni J, Tuset M, Brunet M, Cofan F, Crespo G, Ruiz P, Redondo-Pachón D, Crespo M, Marín-Casino M, Moreno A, Miró JM; Hospital Clinic and Hospital del Mar SOT in HIV Investigators. Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review. Infect Dis Ther 2021;10:1055-64. [PMID: 33830489 DOI: 10.1007/s40121-021-00430-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Morales MK, Lambing T, Husson J. Review: Evaluation and Management of the HIV/HCV Co-Infected Kidney or Liver Transplant Candidate. Curr Treat Options Infect Dis 2020;12:87-111. [DOI: 10.1007/s40506-020-00220-x] [Reference Citation Analysis]
6 Rossotti R, Merli M, Mazzarelli C, De Carlis RM, Travi G, Vecchi M, Viganò R, Lauterio A, Raimondi A, Belli LS, De Carlis LG, Puoti M. Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.05.001] [Reference Citation Analysis]
7 Cachay ER, Mena A, Morano L, Benitez L, Maida I, Mendoza C, Hill L, Torriani F, Soriano V, Mathews WC; HCV-HIV Transatlantic Research Network (HCV-TREN). Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach. J Int Assoc Provid AIDS Care 2021;20:23259582211024771. [PMID: 34132142 DOI: 10.1177/23259582211024771] [Reference Citation Analysis]